» Articles » PMID: 24758658

Characterization of Lipid-poor Adrenal Adenoma: Chemical-shift MRI and Washout CT

Overview
Specialties Oncology
Radiology
Date 2014 Apr 25
PMID 24758658
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of this article is to retrospectively compare the accuracy of MRI and CT in characterizing lipid-poor adrenal adenomas with respect to lesion-attenuation values measured on unenhanced CT.

Materials And Methods: Fifty-two lipid-poor adrenal masses measuring greater than 10 HU on unenhanced CT were identified in 52 patients who underwent both chemical-shift MRI and washout CT. Accuracies using the adrenal-to-spleen ratio (< 0.71) or signal intensity index (> 16.5%) for MRI and using absolute (≥ 60%) or relative (≥ 40%) percentage washout for CT were calculated to determine which modality was more accurate for lipid-poor adenoma characterization. Sensitivities of MRI and CT were also compared according to the lesion-attenuation values measured on unenhanced CT. Follow-up imaging or histologic diagnosis was used as the standard reference. The McNemar test was used to compare the accuracies of CT and MRI.

Results: Lipid-poor adrenal masses consisted of 37 adenomas and 15 nonadenomas. The sensitivities and specificities for adenoma on MRI versus CT were 75.7% (28/37) versus 100% (37/37) and 60.0% (9/15) versus 80.0% (12/15), respectively. CT achieved a higher accuracy than did MRI (p = 0.008). The sensitivities for adenomas measuring 20 HU or less on unenhanced CT were 100% (12/12) in both MRI and CT, whereas those measuring more than 20 HU were 64.0% (16/25) and 100% (25/25) in MRI and CT, respectively.

Conclusion: MRI is equivalent to CT for characterizing adenomas measuring 20 HU or less on unenhanced CT. However, MRI is inferior to CT for adenomas measuring more than 20 HU because of decreased MR sensitivity.

Citing Articles

Adrenal Mass Evaluation: Suspicious Radiological Signs of Malignancy.

Grazzini G, Pradella S, De Litteris F, Galluzzo A, Anichini M, Treballi F Cancers (Basel). 2025; 17(5).

PMID: 40075696 PMC: 11899669. DOI: 10.3390/cancers17050849.


Biomarkers of systemic treatment response: MR images of intratumoral fat deposition in colorectal liver metastases (CRLM) after chemotherapy.

Morawska I, Pasicz K, Cieszanowski A Int J Colorectal Dis. 2024; 39(1):185.

PMID: 39562379 PMC: 11576797. DOI: 10.1007/s00384-024-04762-0.


Quantitative imaging biomarkers in the assessment of adrenal nodules.

Yalon M, Navin P Abdom Radiol (NY). 2024; .

PMID: 39532734 DOI: 10.1007/s00261-024-04671-4.


Feasibility of extracellular volume fraction derived from single-phase spectral CT for differentiating between adrenal metastases and adenomas.

Sun M, Ma S, Tang G, Deng W, Peng Y, Yu S Abdom Radiol (NY). 2024; .

PMID: 39511028 DOI: 10.1007/s00261-024-04681-2.


Differentiate adrenal lipid-poor adenoma from nodular hyperplasia with CT quantitative parameters: a feasibility study.

Bai X, Xu L, Zhang X, Zheng H, Zhang H, Zhang Y Abdom Radiol (NY). 2024; .

PMID: 39425754 DOI: 10.1007/s00261-024-04642-9.